Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Chapter2on Nov 20, 2017 6:09pm
311 Views
Post# 26999654

RE:RE:Cannimed agreed to a merger they agreed I posted the link

RE:RE:Cannimed agreed to a merger they agreed I posted the link Very odd day.... just throwing darts here.... slow decline in CMED shares might have been a start to selling off the 38%.... would be interesting to know who was selling today.  The departure of CMED BD “Rob Duguid” hasn’t been talked a lot about. Not sure if that has anything to do with it.... If CMED wants to go on there own....  stall news and go silent...make a deal with departing BD.... Disolve yourself of your position while we determine what to do... sell the shares down on the open market... refuse deal and force them to buy them at the price they want to sell....silence is ominous... then again they could sell it down.... knowing they have a 24$ offer on the table... and merge.

the opportunity for all partners in this to take it the next level is astonishing.....if it does go through. Really opens the door for a large pharmacy to buy stake in the bigger company. Just the pharmacy access alone CMED brings to the table legitimizes the investment and larger partnership for big pharma....in North America. Never mind the products they have developed. Add the production capacity, hemp assets, extraction tech and distribution facility/access ACB has...you’ve got a world leader in cannabis  Global access adds another dimension entirely...given the cannadis discussions happening and social climate in countries with huge populations, disposable income and emerging commercial economies.

Times are exciting! 

might be way out there though... and the refusal could cause a sell off of “tech-bubble” proportion given the investor demographic make up in the current market..... but it will go back up... ACB is simply to large, organized and attractive in this market to go anywhere but up.

cheers,
chapter2



Bullboard Posts